{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:02:02Z","timestamp":1780038122087,"version":"3.53.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hemoptysis frequently prompts emergency bronchial artery embolization (BAE), and bacterial infection is a common and modifiable trigger. As structural lung disease shapes airway microbiology, pathogen profiles may differ according to the structural lung disease phenotype and could inform empiric antibiotic selection in patients undergoing BAE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed consecutive patients who underwent BAE for hemoptysis at a tertiary referral center between January 2021 and December 2025. Structural lung disease was stratified into three categories based on computed tomography findings: (1) absence of structural lung disease, (2) bronchiectasis, or (3) emphysema\/interstitial lung disease (ILD). Respiratory specimens (sputum or bronchial washing fluid) were evaluated using standard cultures and multiplex polymerase chain reaction (mPCR), when ordered clinically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 188 patients were included [absence of structural lung disease (\n                      <jats:italic>n<\/jats:italic>\n                      = 70), bronchiectasis (\n                      <jats:italic>n<\/jats:italic>\n                      = 96), or emphysema\/ILD (\n                      <jats:italic>n<\/jats:italic>\n                      = 22)]. Overall, 77 patients (41.0%) showed ositive culture or mPCR results. The most commonly identified bacteria were\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      (14.3%) in patients without structural lung disease,\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (29.2%) in patients with bronchiectasis, and\n                      <jats:italic>Klebsiella pneumoniae subsp. pneumoniae<\/jats:italic>\n                      (18.2%) in patients with emphysema\/ILD.\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      was more frequent in patients with bronchiectasis than in those without structural lung disease (29.2% vs. 1.4%,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001).\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      was detected more frequently in 18.2% of patients with emphysema\/ILD and in 5.7% of those without structural lung disease (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.090).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients who underwent BAE showed distinct bacterial profiles according to their underlying structural lung disease. These differences may suggest that tailoring empiric antibiotics according to the structural lung disease phenotype could be considered when an infection is suspected in patients with hemoptysis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1852948","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:07:50Z","timestamp":1780034870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct bacterial profiles according to structural lung disease in patients undergoing bronchial artery embolization for hemoptysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ui Won","family":"Ko","sequence":"first","affiliation":[{"name":"Department of Allergy, Pulmonology and Critical Care Medicine, Gil Medical Center, Gachon University College of Medicine","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihyeon","family":"Heo","sequence":"additional","affiliation":[{"name":"Department of Allergy, Pulmonology and Critical Care Medicine, Gil Medical Center, Gachon University College of Medicine","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyoung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gil Medical Center, Gachon University College of Medicine","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Han","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Gil Medical Center, Gachon University College of Medicine","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beomsu","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Allergy, Pulmonology and Critical Care Medicine, Gil Medical Center, Gachon University College of Medicine","place":["Incheon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1016\/j.jacr.2020.01.043","article-title":"ACR Appropriateness Criteria(R) Hemoptysis.","volume":"17","author":"Olsen","year":"2020","journal-title":"J Am Coll Radiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1186\/s12890-025-04000-5","article-title":"New insights on Bronchial Artery Embolization (BAE) for hemoptysis: a systematic review.","volume":"25","author":"Ravetta","year":"2025","journal-title":"BMC Pulm Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12890-024-03244-x","article-title":"Bronchial artery embolization versus conservative treatment for hemoptysis: a systematic review and meta-analysis.","volume":"24","author":"Fan","year":"2024","journal-title":"BMC Pulm Med."},{"key":"B4","first-page":"144","article-title":"Hemoptysis: evaluation and management.","volume":"105","author":"O\u2019Gurek","year":"2022","journal-title":"Am Fam Physician."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1038\/s41598-021-83524-2","article-title":"Comparative analysis of the alveolar microbiome in COPD, ECOPD, Sarcoidosis, and ILD patients to identify respiratory illnesses specific microbial signatures.","volume":"11","author":"Gupta","year":"2021","journal-title":"Sci Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1602086","DOI":"10.1183\/13993003.02086-2016","article-title":"The microbiome in respiratory medicine: current challenges and future perspectives.","volume":"49","author":"Faner","year":"2017","journal-title":"Eur Respir J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0140-6736(14)61136-3","article-title":"The role of the microbiome in exacerbations of chronic lung diseases.","volume":"384","author":"Dickson","year":"2014","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the us bronchiectasis research registry.","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.","volume":"51","author":"Araujo","year":"2018","journal-title":"Eur Respir J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC).","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","article-title":"Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.","volume":"17","author":"Baur","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1001\/jama.2024.6248","article-title":"Stewardship prompts to improve antibiotic selection for pneumonia: the INSPIRE randomized clinical trial.","volume":"331","author":"Gohil","year":"2024","journal-title":"JAMA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults.","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax."},{"key":"B14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1148\/radiol.2015141579","article-title":"CT-Definable subtypes of chronic obstructive pulmonary disease: a statement of the fleischner society.","volume":"277","author":"Lynch","year":"2015","journal-title":"Radiology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1164\/rccm.202505-1142SO","article-title":"Standardized clinical terms and definitions for interstitial lung disease: a consensus statement from the fleischner society.","volume":"211","author":"Ryerson","year":"2025","journal-title":"Am J Respir Crit Care Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","article-title":"Lung microbiome: new insights into the pathogenesis of respiratory diseases.","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1164\/rccm.202112-2704PP","article-title":"Therapeutic targeting of the respiratory microbiome.","volume":"206","author":"Chotirmall","year":"2022","journal-title":"Am J Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12931-021-01820-x","article-title":"Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis.","volume":"22","author":"Hwang","year":"2021","journal-title":"Respir Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.11604\/pamj.2015.22.378.7775","article-title":"Bronchiectasis: a bacteriological profile.","volume":"22","author":"Bopaka","year":"2015","journal-title":"Pan Afr Med J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.","volume":"132","author":"Martinez-Garcia","year":"2007","journal-title":"Chest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1183\/09031936.00119114","article-title":"Management of bronchiectasis in adults.","volume":"45","author":"Chalmers","year":"2015","journal-title":"Eur Respir J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12931-023-02391-9","article-title":"Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study.","volume":"24","author":"Wang","year":"2023","journal-title":"Respir Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s12931-024-03019-2","article-title":"Multi-drug resistant Pseudomonas aeruginosa isolation is an independent risk factor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a retrospective cohort study.","volume":"25","author":"Sun","year":"2024","journal-title":"Respir Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3390\/ijms23020977","article-title":"Lung microbiome in idiopathic pulmonary fibrosis and other interstitial lung diseases.","volume":"23","author":"Amati","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease.","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S2213-2600(18)30510-1","article-title":"Functional effects of the microbiota in chronic respiratory disease.","volume":"7","author":"Budden","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0140-6736(25)01493-X","article-title":"Community-acquired pneumonia.","volume":"406","author":"Reyes","year":"2025","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1056\/NEJMcp2303286","article-title":"Community-Acquired pneumonia.","volume":"389","author":"File","year":"2023","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the american thoracic society and infectious diseases society of America.","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00408-017-0064-8","article-title":"Severe hemoptysis associated with bacterial pulmonary infection: clinical features, significance of parenchymal necrosis, and outcome.","volume":"196","author":"Carteaux","year":"2018","journal-title":"Lung."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1097\/01.CCM.0000220496.48295.A9","article-title":"Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia.","volume":"34","author":"Witzenrath","year":"2006","journal-title":"Crit Care Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13244-020-00877-4","article-title":"Evaluation of the bronchial arteries: normal findings, hypertrophy and embolization in patients with hemoptysis.","volume":"11","author":"Almeida","year":"2020","journal-title":"Insights Imaging."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0131325","DOI":"10.1128\/jcm.01313-25","article-title":"Impact of multiplex PCR point-of-care platform implementation for respiratory pathogen detection in an emergency department with high daily patient volume.","volume":"64","author":"Bigaud","year":"2026","journal-title":"J Clin Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"ofad382","DOI":"10.1093\/ofid\/ofad382","article-title":"Implementation of a rapid multiplex polymerase chain reaction pneumonia panel and subsequent antibiotic de-escalation.","volume":"10","author":"Miller","year":"2023","journal-title":"Open Forum Infect Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jinf.2023.03.005","article-title":"Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: results of a systematic review and meta-analysis.","volume":"86","author":"Clark","year":"2023","journal-title":"J Infect."},{"key":"B36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s42155-025-00551-0","article-title":"Long term outcomes following embolisation of bronchial and non-bronchial systemic arteries for the management of haemoptysis - a 20-year experience.","volume":"8","author":"Patel","year":"2025","journal-title":"CVIR Endovasc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/0366-6999.147811","article-title":"Bronchial artery embolization for hemoptysis: a retrospective observational study of 344 patients.","volume":"128","author":"Shao","year":"2015","journal-title":"Chin Med J."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1852948\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:07:51Z","timestamp":1780034871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1852948\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1852948"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1852948","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1852948"}}